Abstract

  


 



Clinical Trials - The Situation in Belgium in the Light of Recent Case Law in the Netherlands and Germany (Proeven met geneesmiddelen - De situatie in België in het licht van de recente rechtspraak en rechtsleer in Nederland en Duitsland)


Geertrui Van Overwalle


Leuven University; Tilburg University
December 1, 2010

PATENT LAW AND MEDICINES, pp. 65-91, G. Van Overwalle, ed., Brussel, Bruylant, 2000

Abstract:     
The paper discusses the scope of patents for medicines, and analyses which acts from third parties, ranging from clinical trials from competitors for improved medicines to generic manufacturers with me-too products, the patent holder can stop.

Note: Downloadable document is in Dutch.

Number of Pages in PDF File: 26

Keywords: Patents, medicines, clinical trials, research exemption

JEL Classification: I18, K11, O32, O34, H51

Accepted Paper Series


Download This Paper

Date posted: December 2, 2010  

Suggested Citation

Van Overwalle, Geertrui , Clinical Trials - The Situation in Belgium in the Light of Recent Case Law in the Netherlands and Germany (Proeven met geneesmiddelen - De situatie in België in het licht van de recente rechtspraak en rechtsleer in Nederland en Duitsland) (December 1, 2010). PATENT LAW AND MEDICINES, pp. 65-91, G. Van Overwalle, ed., Brussel, Bruylant, 2000. Available at SSRN: http://ssrn.com/abstract=1718624

Contact Information

Geertrui Van Overwalle (Contact Author)
Leuven University ( email )
Minderbroedersstraat 5
Leuven, B-3000
Belgium
Tilburg University ( email )
PO Box 90153
Tilburg, NL-5000 LE
Netherlands
Feedback to SSRN (Beta)


Paper statistics
Abstract Views: 131
Downloads: 23
Paper comments
No comments have been made on this paper

© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright
This page was processed by apollo1 in 0.375 seconds